Curaleaf stock: Curaleaf responds to Alberta ruling. Third-quarter results test Curaleaf stock

Published on 10/28/2026 at 06:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Curaleaf answered an Alberta securities decision on October 27, 2026. Curaleaf stock reports third-quarter results on November 3, 2026.

Upcoming reporting and operating scale

Curaleaf responded to an Alberta securities decision on October 27, 2026.
Second-quarter revenue reached USD 340.10 million and net income was USD 12.50 million.
Curaleaf will report third-quarter results on November 3, 2026.

CURA, CA23126M1023, Illustration mit AI erstellt.

Curaleaf Holdings (ISIN CA23126M1023) responded to an Alberta securities decision on October 27, 2026, while third-quarter results are scheduled for November 3, 2026. The company said the earnings release will follow the market close, with a conference call at 5:00 p.m. ET, according to Curaleaf.

Three events reshape the timeline

On June 5, 2026, Curaleaf completed a 1-for-3 reverse stock split, according to Simply Wall St. On August 11, 2026, it proposed a USD 270.00 million acquisition of Aurora Cannabis. On October 27, 2026, the company responded to the Alberta securities decision, marking the latest dated development in the sequence.

What does the Q2 rebound mean?

Curaleaf's second-quarter 2026 revenue was USD 340.10 million, up 5.00 percent sequentially from USD 324.23 million in the first quarter, while net income reached USD 12.50 million after a USD 60.74 million loss in the fourth quarter of 2025, according to Simply Wall St. The figures put operating execution beside the regulatory and transaction agenda. Cash from operating activities was USD 28.49 million in the second quarter, while capital spending was USD 15.53 million.

Next dates carry the focus

Curaleaf's next substantiated company date is November 3, 2026, when it will publish third-quarter results for the period ended September 30, 2026. The related conference call starts at 5:00 p.m. ET, and the replay remains available through November 10, 2026, according to Curaleaf. The report will show whether the second-quarter revenue increase and return to net income continued into the third quarter.

Curaleaf combines retail and wholesale operations

Curaleaf operates in medical and adult-use cannabis through cultivation, manufacturing, retail and wholesale activities. Its investor-relations page lists 164 dispensaries and 15 cultivation sites as of the first quarter of 2026, with operations across 15 US states and international activity in 16 countries.